SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

1 hedge funds and large institutions have $1.9M invested in Sonnet BioTherapeutics in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$396K

Top Sellers

1
-$996K
2
-$981K
3
-$717K
4
Millennium Management
Millennium Management
New York
-$498K
5
BIT
BlackRock Institutional Trust
California
-$250K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$396K
2
$300K
3
$229K
4
$227K
5
$136K
6
$111K
7
$101K
8
$88K
9
$72K
10
$67K
11
$53K
12
$49K
13
$26K
14
$19K
15
$15K
16
$5K
17
$1K
18
–
19
–
20
–
21
–
22
–